Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Burrow

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Stroke|September 9, 2022
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute PhaseAnita van de Munckhof, Erik Lindgren, Timothy J Kleinig, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
JAMA Neurology|September 28, 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic ThrombocytopeniaMayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Stroke|September 9, 2022
Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute PhaseAnita van de Munckhof, Erik Lindgren, Timothy J Kleinig, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
JAMA Neurology|September 28, 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic ThrombocytopeniaMayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, et al.
Pageof 1